Viking Therapeutics Shares Rise Following Takeover Speculation
Shares of Viking Therapeutics (VKTX) climbed 4.1% following reports suggesting renewed interest from potential acquirers. The speculation stems from a market alert circulating on Friday, though the identity of any prospective suitor remains unconfirmed by traders. The movement comes amid heightened industry interest in metabolic and obesity drug developers. While no official merger or acquisition activity has been announced, the rumors have provided upward momentum for VKTX in recent trading sessions.
Topics: biotechnology stock price increase takeover speculation
Read the full article at Seeking Alpha
Part of the story Clorox Shares Rise on Speculation of Potential Takeover Bid (3 articles)